Propofol interacts with stimulus intensities of electroconvulsive shock to regulate behavior and hippocampal BDNF in a rat model of depression

Psychiatry Research

Volumn 198, Issue 2, 2012, Pages 300-306

  Luo, Jie ^a   Min, Su ^a   Wei, Ke ^a   Zhang, Junfang ^a   Liu, Yuanyuan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Anesthetics; Electroconvulsive therapy; Intravenous; Nerve growth factors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PROPOFOL; SODIUM CHLORIDE; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CONTROL; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ELECTROCONVULSIVE THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOKED RESPONSE; FOOD PREFERENCE; HIPPOCAMPUS; MALE; NERVE STIMULATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REARING; SEIZURE THRESHOLD; THERAPY EFFECT;

ANESTHETICS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DISEASE MODELS, ANIMAL; ELECTROCONVULSIVE THERAPY; HIPPOCAMPUS; MALE; PROPOFOL; RATS; SEIZURES;

EID: 84868116825     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.09.010     Document Type: Article

References (34)

1. Altar C.A. Neurotrophins and depression. Trends in Pharmacological Sciences 1999, 20:59-61.
2. Altar C.A., Whitehead R.E., Chen R., Wortwein G., Madsen T.M. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biological Psychiatry 2003, 54:703-709.
3. Andrade C., Kurinji S., Sudha S., Chandra J.S. Effects of pulse amplitude, pulse frequency, and stimulus duration on seizure threshold: a laboratory investigation. The Journal of ECT 2002, 18:144-148.
4. Andrade C., Thyagarajan S., Vinod P.S., Srikanth S.N., Rao N.S., Chandra J.S. Effect of stimulus intensity and number of treatments on ECS-related seizure duration and retrograde amnesia in rats. The Journal of ECT 2002, 18:197-202.
5. Bauer J., Hageman I., Dam H., Baez A., Bolwig T., Roed J., Olsen N.V., Jorgensen M.B. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT 2009, 25:85-90.
6. Bowdle T.A., Radant A.D., Cowley D.S., Kharasch E.D., Strassman R.J., Roy-Byrne P.P. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 1998, 8:82-88.
7. Butterfield N.N., Graf P., Macleod B.A., Ries C.R., Zis A.P. Propofol reduces cognitive impairment after electroconvulsive therapy. The Journal of ECT 2004, 20:3-9.
8. Corlett P.R., Honey G.D., Aitken M.R., Dickinson A., Shanks D.R., Absalom A.R., Lee M., Pomarol-Clotet E., Murray G.K., McKenna P.J., Robbins T.W., Bullmore E.T., Fletcher P.C. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Archives of General Psychiatry 2006, 63:611-621.
9. Cronholm B., Ottosson J.O. Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure studied by variation of stimulus intensity and modification by lidocaine of seizure discharge. Convulsive Therapy 1996, 12:172-194.
10. Dong J., Min S., Wei K., Li P., Cao J., Li Y. Effects of electroconvulsive therapy and propofol on spatial memory and glutamatergic system in hippocampus of depressed rats. The Journal of ECT 2010, 26:126-130.
11. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 1997, 54:597-606.
12. Eranti S.V., Mogg A.J., Pluck G.C., Landau S., McLoughlin D.M. Methohexitone, propofol and etomidate in electroconvulsive therapy for depression: a naturalistic comparison study. Journal of Affective Disorders 2009, 113:165-171.
13. Erdil F., Demirbilek S., Begec Z., Ozturk E., Ersoy M.O. Effects of propofol or etomidate on QT interval during electroconvulsive therapy. The Journal of ECT 2009, 25:174-177.
14. Eser D., Nothdurfter C., Schüle C., Damm J., Steng Y., Möller H.J., Rupprecht R., Baghai T. The influence of anaesthetic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. The World Journal of Biological Psychiatry 2010, 11:447-456.
15. Garcia-Cairasco N., Oliveira J.A., Wakamatsu H., Bueno S.T., Guimaraes F.S. Reduced exploratory activity of audiogenic seizures susceptible Wistar rats. Physiology & Behavior 1998, 64:671-674.
16. Gareri P., Falconi U., De Fazio P., De Sarro G. Conventional and new antidepressant drugs in the elderly. Progress in Neurobiology 2000, 61:353-396.
17. Geretsegger C., Nickel M., Judendorfer B., Rochowanski E., Novak E., Aichhorn W. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT 2007, 23:239-243.
18. Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry and Clinical Neurosciences 2010, 64:341-357.
19. Kikuchi A., Yasui-Furukori N., Fujii A., Katagai H., Kaneko S. Identification of predictors of post-ictal delirium after electroconvulsive therapy. Psychiatry and Clinical Neurosciences 2009, 63:180-185.
20. Li N., He X., Zhang Y., Qi X., Li H., Zhu X., He S. Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigine. The International Journal of Neuropsychopharmacology 2010, 16:1-8.
21. Luo K.R., Hong C.J., Liou Y.J., Hou S.J., Huang Y.H., Tsai S.J. Differential regulation of neurotrophin S100B and BDNF in two rat models of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2010, 34:1433-1439.
22. Mitchell P., Torda T., Hickie I., Burke C. Propofol as an anaesthetic agent for ECT: effect on outcome and length of course. The Australian and New Zealand Journal of Psychiatry 1991, 25:255-261.
23. O'Reardon J.P., Takieddine N., Datto C.J., Augoustides J.G. Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series. The Journal of ECT 2006, 22:247-252.
24. Qi X., Lin W., Li J., Li H., Wang W., Wang D., Sun M. Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiology of Disease 2008, 31:278-285.
25. Quante A., Luborzewski A., Brakemeier E.L., Merkl A., Danker-Hopfe H., Bajbouj M. Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: a randomized, double-blind pilot study. Journal of Psychiatric Research 2011, 45:174-178.
26. Rampton A.J., Griffin R.M., Durcan J.J., Stuart C.S. Propofol and electroconvulsive therapy. Lancet 1988, 1:296-297.
27. Sackeim H.A., Devanand D.P., Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. The Psychiatric Clinics of North America 1991, 14:803-843.
28. Sackeim H.A., Prudic J., Devanand D.P., Kiersky J.E., Fitzsimons L., Moody B.J., McElhiney M.C., Coleman E.A., Settembrino J.M. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. The New England Journal of Medicine 1993, 328:839-846.
29. Sarkisova K.Y., Kulikov M.A. Behavioral characteristics of WAG/Rij rats susceptible and non-susceptible to audiogenic seizures. Behavioural Brain Research 2006, 166:9-18.
30. Segi-Nishida E., Warner-Schmidt J.L., Duman R.S. Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:11352-11357.
31. Simpson K.H., Halsall P.J., Carr C.M., Stewart K.G. Propofol reduces seizure duration in patients having anaesthesia for electroconvulsive therapy. British Journal of Anaesthesia 1988, 61:343-344.
32. Wang X., Yang Y., Zhou X., Wu J., Li J., Jiang X., Qu Q., Ou C., Liu L., Zhou S. Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test. Psychiatry Research 2011, 185:248-253.
33. Warnell R.L., Swartz C.M., Thomson A. Propofol interruption of ECT seizure to reduce side-effects: a pilot study. Psychiatry Research 2010, 175:184-185.
34. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997, 134:319-329.